- Home
- ESEA vs AQST Comparison
ESEA vs AQST Comparison
Compare ESEA & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESEA | AQST |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 484.0M | 529.4M |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ESEA | AQST |
|---|---|---|
| Price | $69.80 | $4.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $62.00 | $9.00 |
| AVG Volume (30 Days) | 45.6K | ★ 2.3M |
| Earning Date | 06-17-2026 | 05-01-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,430,000.00 |
| Revenue This Year | $1.74 | $10.08 |
| Revenue Next Year | $1.07 | $49.60 |
| P/E Ratio | $3.39 | ★ N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $48.89 | $2.94 |
| 52 Week High | $78.76 | $7.55 |
Technical Indicators
Market Signals| Indicator | ESEA | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 41.73 |
| Support Level | $63.64 | $3.74 |
| Resistance Level | $72.24 | $4.38 |
| Average True Range (ATR) | 2.29 | 0.17 |
| MACD | 0.17 | -0.04 |
| Stochastic Oscillator | 61.39 | 29.45 |
Price Performance
Historical ComparisonAbout ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.